Companies added IVF coverage when workers were scarce. Employers now have the upper hand, but the national focus on the declining birthrate could protect these benefits.
Two college students lost their best friend to ovarian cancer. Here’s how they turned grief into a growing movement to honor her legacy.
As interest in peptide therapy continues to grow, CeliaRx is positioning itself as a trusted destination for personalized, physician-guided peptide care.
It was a banner year for the country’s most successful women with a record number of billionaires, soaring fortunes thanks to AI and an all-time high in total wealth.
A physician assistant with no symptoms and a clear colonoscopy was three years from her next screening. A blood test found Stage 3 colon cancer
PCOS has been renamed PMOS. Here’s what the change means for the millions of women living with this misunderstood, often misdiagnosed condition
Learfield is intentionally hiring former collegiate athletes to lead their NIL partnerships on collegiate campuses, leading to 40% growth in brand engagement.
Nearly 200 blood proteins rise and fall across the menstrual cycle, enabling a test that pinpoints cycle day and links it to risks like fibroids and heavy bleeding.
An overactive immune switch in the placenta may drive preeclampsia; blocking it in models reverses key disease pathways, pointing toward targeted therapies.
New experiential research highlights that women over 45 may have hopeful outcomes for fertility via IVF and natural conception.